Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial

BACKGROUND: It is recommended that children aged 3 months to five years of age living in areas of seasonal transmission in the sub-Sahel should receive Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine plus amodiaquine (SPAQ) during the malaria transmission season. The purpose of...

Descripción completa

Detalles Bibliográficos
Autores principales: NDiaye, J. L., Cissé, B., Ba, E. H., Gomis, J. F., Ndour, C. T., Molez, J. F., Fall, F. B., Sokhna, C., Faye, B., Kouevijdin, E., Niane, F. K., Cairns, M., Trape, J. F., Rogier, C., Gaye, O., Greenwood, B. M., Milligan, P. J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072628/
https://www.ncbi.nlm.nih.gov/pubmed/27764102
http://dx.doi.org/10.1371/journal.pone.0162563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072628/
https://www.ncbi.nlm.nih.gov/pubmed/27764102
http://dx.doi.org/10.1371/journal.pone.0162563

Ejemplares similares